Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Swap Your Diet, Swap Your Cancer Risk, New Study Finds

If you weren’t quite convinced that you are, at least mostly, what you eat, a new study should help persuade you. Researchers from the University of Pittsburgh, Imperial College London, Wageningen University in the Netherlands, University of Helsinki, University of Illinois, and the University of KwaZulu-Natal in South Africa followed participants in the U.S. and in South Africa, asking each […]

Read More »

Study Demonstrates Potential Of Rapid Whole-Genome Sequencing In Critically Ill Infants

KANSAS CITY, Mo., April 27, 2015 /PRNewswire/ — A study published today in The Lancet Respiratory Medicine and presented at the annual Pediatric Academic Societies Meeting reveals the early results of the clinical usefulness of rapid whole-genome sequencing in neonatal and pediatric intensive care units (NICUs and PICUs). Children’s Mercy Kansas City’s STAT-Seq test helped diagnose […]

Read More »

Cardiovascular Outcomes With Merck’s Januvia: No Better Or Worse Than Conventional Care

Late Monday afternoon Merck released the top line results of TECOS, the cardiovascular outcomes trial with its blockbuster diabetes drug Januvia (sitagliptin).  The company said that the trial “achieved its primary endpoint of non-inferiority for the composite cardiovascular (CV) endpoint.” Merck announced only one additional detail: “Among secondary endpoints,” they reported, “there was no increase […]

Read More »

Reading to young kids may change brain activation

<span class="articleLocation”>(Reuters Health) – Reading to small children may help prepare their brains for reading-readiness, a new study suggests. In pre-kindergarten kids who were exposed to more reading at home, brain scans showed different patterns of brain activation than in kids who weren’t read to, researchers found. The American Academy of Pediatrics recommends that new […]

Read More »

More Power to the Mitochondria: Cells' Energy Plant Also Plays Key Role in Stem Cell Development

NEW YORK, April 27, 2015 /PRNewswire-USNewswire/ — Researchers at NYU Langone Medical Center have discovered that mitochondria, the major energy source for most cells, also play an important role in stem cell development — a purpose notably distinct from the tiny organelle’s traditional job as the cell’s main source of the adenosine triphosphate (ATP) energy […]

Read More »

Celladon to cut jobs as gene therapy fails key trial; stock plunges

(Reuters) – Drug developer Celladon Corp said it expected to announce lay-offs and cost cuts as its stock plunged to an all-time low after the company’s lead experimental gene therapy to treat heart failure failed a key trial. Celladon lost nearly 80 percent of its market value in early trading on Monday, with the stock […]

Read More »

Susan G. Komen Hails Discovery of New Breast Cancer Susceptibility Gene

DALLAS–(BUSINESS WIRE)–Susan G. Komen today hailed the discovery of a breast cancer susceptibility gene known as RECQL which the organization says could one day lead to more options for women to identify and take steps to reduce their breast cancer risk. The discovery project, led by Dr. Mohammad Akbari at the University of Toronto, was […]

Read More »

Advanced Proteome Therapeutics Reports Successful Fusion Protein Initiative Resulting in APC 103 Which Retards Tumor Growth in an Animal Model

VANCOUVER, BC–(Marketwired – April 27, 2015) – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSX VENTURE: APC) (FRANKFURT: 0E8) is pleased to announce that its new fusion protein, APC 103, exhibited enhanced activity over the parent protein in retarding tumor growth in animal studies, comparable to APC 101 which has been the Company’s principal […]

Read More »

Neurovive Pharmaceutical: FIrst Patient Enrolled in Clinical Phase II Study for Kidney Protection During Heart Surgery

STOCKHOLM–(BUSINESS WIRE)–Regulatory News: NeuroVive Pharmaceutical AB (publ)(STO:NVP), the mitochondrial medicine company, announces that the first patient has been enrolled in a clinical phase II study for acute kidney injury using the company’s product CicloMulsion®. The study, known as CiPRICS, is being conducted by Skåne University Hospital and will evaluate the product’s ability to prevent acute […]

Read More »

BioGaia: Positive Results in First Chinese Study with BioGaia’s Drops in Infants with Colic

STOCKHOLM–(BUSINESS WIRE)–Regulatory News: A Chinese study of infants with colic shows that babies given Lactobacillus reuteri Protectis cry significantly less compared to babies given placebo. The newly published study is the fifth positive colic study with Lactobacillus reuteri Protectis and the results confirm the positive results of earlier studies. 100 per cent treatment successTreatment success […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom